Diligence memo · auto-generated · as of July 2, 2026

Sight Vision Partners, LLC

Sight Vision Partners, LLC looks over-valued against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

Sight Vision Partners, LLC operates in Hospitals and Physicians, based in HAUPPAUGE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Sight Vision Partners, LLC has raised $3.9M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $2.5M on 2023-03-27.

Most recent recorded round closed around 2023-03-27.

Valuation (modeled)modeled

Provath models Sight Vision Partners, LLC at approximately $19M (range $2.2M–$71M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.68× the median modeled value of Seed Hospitals and Physicians companies in 2022–2024 (23 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 20 months.

Last raise 3.3 yr ago; this sector typically re-raises about every 12 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round stepped up 1.8× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 66% of Hospitals and Physicians peers (599 compared).

Modeled value ranks above 45% of those peers.

Closest niche peers: Maplemere Ventures LLC, San Joaquin Valley Surgery Center, LLC, Specialty Surgical Center of Encino LLC, RemoteMD International, Inc., Great Seal Surgery Center, LLC.

Peoplefiled

3 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.